Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Roger Jeffs Insider Profile
4 Followers
Roger Jeffs, President & Co-CEO, Director at United Therapeutics, holds 2.42M shares in Liquidia Technologies (Ticker: LQDA), holds 167.67K shares in Axsome Therapeutics (Ticker: AXSM), holds 0.00 shares in Dova Pharmaceuticals (Ticker: DOVA).
Roger Jeffs United Therapeutics (UTHR)President & Co-CEO, Director
United Therapeutics (UTHR)
President & Co-CEO, Director
Ranked #1,826 out of 98,743 Corporate Insiders
Profitable Transactions
10 out of 13 Profitable Transactions
Average Return
+43.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Roger Jeffs holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jul 05, 2019 - Jul 05, 2020
Return:+199.40%
The most profitable trade made by Roger Jeffs
Roger Jeffs's Trading History
United Therapeutics
Feb 17, 2016
President & Co-CEO, Director
Uninformative Sell
1.14M
$7.06M
Axsome Therapeutics
Mar 15, 2024
Director
Uninformative Sell
2.26M
$12.73M
Sangamo Biosciences
Sep 07, 2018
Director
Informative Buy
100.45K
$5.21K
Sio Gene Therapies
―
―
―
―
Albireo Pharma
―
―
―
―
Dova Pharmaceuticals
Nov 12, 2019
―
Uninformative Sell
―
$0.00
Liquidia Technologies
Apr 16, 2024
CEO, Director
Uninformative Sell
121.89K
$30.65M
List of latest transactions for each holding click on a transaction to see Roger Jeffs's performance on stock
You May Also Like
Roger Jeffs insider profile FAQ
What is the percentage of profitable transactions made by Roger Jeffs?
The percentage of profitable transactions made by Roger Jeffs is 77%.
What is the average return per transaction made by Roger Jeffs?
The average return per transaction made by Roger Jeffs is 43.70%.
What stocks does Roger Jeffs hold?
Roger Jeffs holds: UTHR, AXSM, SGMO, SIOX, ALBO, DOVA, LQDA stocks.
What was Roger Jeffs’s latest transaction?
Roger Jeffs latest transaction was an Uninformative Sell of $121.89K.
What was Roger Jeffs's most profitable transaction?
Roger Jeffs’s most profitable transaction was an Informative Buy of AXSM stock on July 5, 2019. The return on the trade was 199.40%.
What is Roger Jeffs's role in United Therapeutics?
Roger Jeffs's role in United Therapeutics is President & Co-CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.